Results of TRIAS 2009 trial of sorafenib with topotecan in ovarian cancer

Jalid Sehouli, MD, PhD from Charit Comprehensive Cancer Center, Berlin, Germany discusses the Phase II TRIAS 2009 trial of sorafenib with topotecan in patients with platinum-resistant recurrent ovari... Author: VJOncology Added: 08/11/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts